Polycystic ovary syndrome (PCOS) is one of the most common endocrine disorders affecting women of reproductive age and is frequently associated with weight gain, insulin resistance, and hormonal imbalance. A growing body of research suggests that specific nutrients targeting insulin metabolism may help improve metabolic outcomes in women with PCOS.
A multi-center study published in Bioinformation (2022) by Lila Vyas et al evaluated the clinical effectiveness of a combination of Myo-inositol and D-chiro-inositol in women diagnosed with PCOS across India.
What the Study Investigated?
The study titled “Management of polycystic ovary syndrome among Indian women using myo-inositol and D-chiro-inositol” analyzed data collected from 29 healthcare centers across India.
The study included 283 women aged 12–45 years diagnosed with PCOS who received a combination of Myo-inositol and D-chiro-inositol as part of their management plan. Researchers evaluated several clinical outcomes including:
- Body weight changes
- Hormonal markers such as testosterone
- LH/FSH ratio
- Blood glucose and insulin levels
- HOMA-IR (a marker of insulin resistance)
- Hirsutism severity
Weight Reduction Observed in the Study
One of the key findings reported in the study was weight reduction in a majority of participants.
Among the 283 women included in the analysis, 197 women (69.61%) reported a reduction in body weight following treatment with the Myo-inositol and D-chiro-inositol combination.
This suggests that improving insulin signaling with an inositol complex supports metabolic improvements that contribute to weight reduction in women with PCOS.
Improvements in Hormonal Markers
In addition to weight changes, the study reported improvements in several hormonal and metabolic indicators associated with PCOS.
The researchers observed:
- Significant reductions in free testosterone levels
- Decrease in dehydroepiandrosterone (DHEA)
- Improvement in the LH:FSH hormonal ratio
These hormonal improvements are clinically relevant because elevated androgens and disrupted LH/FSH balance are common drivers of symptoms such as weight gain, irregular cycles, and hirsutism in PCOS.
Why Inositol supports Weight Management in PCOS?
Myo-inositol and D-chiro-inositol are naturally occurring compounds that function as insulin-signaling molecules inside cells. Because insulin resistance is a key metabolic feature of PCOS, improving insulin sensitivity can help normalize hormonal pathways that influence body weight and metabolism.
By improving insulin signaling, inositol complexes may indirectly support:
- Better glucose metabolism,
- Reduced androgen excess,
- Improved metabolic balance
These metabolic improvements may contribute to the weight reductions observed in clinical studies.
Nutritional Delivery of Inositol
Because PCOS management often involves both nutritional strategies and metabolic support, some nutritional products now incorporate inositol complexes as part of their formulation.
For example, neumeal meal replacer for women contains Myo-inositol and D-chiro-inositol , the same ingredients that have been studied for their role in improving metabolic parameters and supporting weight management in women with PCOS.
Takeaway
The multi-center study by Lila Vyas et al , involving 283 women with PCOS found that nearly 70% of participants experienced weight reduction after using a Myo-inositol and D-chiro-inositol combination.
While individual results can vary, the findings support the growing scientific evidence in inositol complexes as a metabolic support strategy for women with PCOS, particularly when combined with balanced nutrition and lifestyle changes.
About the author:
Written by Adithya Reddy, Research Assistant with Neu Nutrition.
0 comments